Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Translational Lung Cancer Research

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.21037/tlcr.2018.02.02PMID 29535911PMCID PMC5835590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.

  2017cited by this paper
• REST corepressors RCOR1 and RCOR2 and the repressor INSM1 regulate the proliferation–differentiation balance in the developing brain

  2017cited by this paper
• MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.

  2017cited by this paper
• Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

  2017cited by this paper
• Small-cell lung cancer: what we know, what we need to know and the path forward

  2017cited by this paper
• Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer

  2017cited by this paper
• Intratumoral heterogeneity generated by Notch signaling promotes small cell lung cancer

  2017cited by this paper
• Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

  2017cited by this paper
• Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.

  2017cited by this paper
• Small-cell lung cancer: what we know, what we need to know and the path forward

  2017cited by this paper
• Correction: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.

  2017cited by this paper
• Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.

  2017cited by this paper
• Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies

  2017cited by this paper
• From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers

  2016cited by this paper
• MYB-fusions and other potential actionable targets in adenoid cystic carcinoma

  2016cited by this paper
• Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.

  2016influential reference
• ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.

  2016cited by this paper
• Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo

  2016cited by this paper
• Elevated ASCL2 expression is associated with metastasis of osteosarcoma and predicts poor prognosis of the patients.

  2016cited by this paper
• YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer

  2016cited by this paper
• Loss of YAP1 defines neuroendocrine differentiation of lung tumors

  2016cited by this paper
• An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer

  2016cited by this paper
• Ascl2 reinforces intestinal stem cell identity.

  2015cited by this paper
• YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment.

  2015cited by this paper
• A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

  2015cited by this paper
• INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms.

  2015influential reference
• Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β-cell function

  2015cited by this paper
• Brain Expressed and X-Linked (Bex) Proteins Are Intrinsically Disordered Proteins (IDPs) and Form New Signaling Hubs

  2015cited by this paper
• Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma

  2015cited by this paper
• EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway

  2015cited by this paper
• Insm1 controls the differentiation of pulmonary neuroendocrine cells by repressing Hes1.

  2015cited by this paper
• Comprehensive genomic profiles of small cell lung cancer

  2015influential reference
• R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability.

  2015cited by this paper
• ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

  2014cited by this paper
• Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• RE-1 silencing transcription factor (REST): a regulator of neuronal development and neuronal/endocrine function

  2014cited by this paper
• Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.

  2014cited by this paper
• MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study

  2014cited by this paper
• The Hippo pathway and human cancer

  2013cited by this paper
• Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.

  2013cited by this paper
• Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations

  2013cited by this paper
• Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.

  2013influential reference
• EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation

  2013cited by this paper
• Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.

  2013cited by this paper
• NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.

  2013cited by this paper
• Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

  2012cited by this paper
• Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

  2012cited by this paper
• A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer.

  2011influential reference
• The Master Negative Regulator REST/NRSF Controls Adult Neurogenesis by Restraining the Neurogenic Program in Quiescent Stem Cells

  2011cited by this paper
• Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic

  2011cited by this paper
• Bex1 is involved in the regeneration of axons after injury

  2010cited by this paper
• Ascl2 and 11p15.5 amplification in colorectal cancer

  2010cited by this paper
• TTF1 expression in normal lung neuroendocrine cells and related tumors: immunohistochemical study comparing two different monoclonal antibodies

  2010cited by this paper
• Insm1 (IA-1) is an essential component of the regulatory network that specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain

  2009cited by this paper
• Identification of novel neuroendocrine-specific tumour genes

  2008cited by this paper
• MYB function in normal and cancer cells

  2008cited by this paper
• Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?

  2007cited by this paper
• Value of the Innovated Technique Agarose Cell Block in Improving the Sensitivity of Urine Cytology in Cases of Bladder Carcinoma

  2006cited by this paper
• NCI‐navy medical oncology branch cell line data base

  1996cited by this paper
• NCI series of cell lines: An historical perspective

  1996cited by this paper
• RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma.

  1994cited by this paper
• myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

  1992cited by this paper
• Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.

  1989cited by this paper
• v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer.

  1988cited by this paper
• Small cell lung cancer cell lines: pure and variant types can be distinguished by their extracellular matrix synthesis.

  1988cited by this paper
• Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.

  1988cited by this paper
• Characterization of three new variant type cell lines derived from small cell carcinoma of the lung.

  1985cited by this paper
• Establishment and identification of small cell lung cancer cell lines having classic and variant features.

  1985cited by this paper
• L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

  1985cited by this paper
• Expression of the c-myb oncogene in human small cell lung carcinoma.

  1985cited by this paper
• Biological heterogeneity of small cell lung cancer.

  1985cited by this paper
• Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.

  1985cited by this paper
• In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants.

  1983cited by this paper
• Amplification and expression of the c-myc oncogene in human lung cancer cell lines

  1983cited by this paper
• Oat‐cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid

  1968cited by this paper
• Cancer Cells Notch Signaling Induces Cell Cycle Arrest in Small Cell Lung Updated Version Cited Articles Citing Articles E-mail Alerts Notch Signaling Induces Cell Cycle Arrest in Small Cell Lung Cancer Cells 1

  year unknowncited by this paper
• Translational Lung Cancer Research

  year unknowncited by this paper
• Cellular Neuroscience Mini Review Article Transcriptional Control of Vertebrate Neurogenesis by the Proneural Factor Ascl1

  year unknowncited by this paper

• Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis

  2026cites this paper
• Novel ImmunoPET Probes [64Cu]Cu-NOTA-GGB02-F9 for Small-Cell Lung Cancer Derived from a SEZ6-Targeting Antibody.

  2026cites this paper
• Integration of ımmunotherapy in limited-stage small cell lung cancer: a review of the literature.

  2026cites this paper
• SMARCA4 loss promotes late-stage tumor progression in non-neuroendocrine small-cell lung cancer.

  2025cites this paper
• Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in small cell lung cancer

  2025cites this paper
• Spatial proteomic profiling reveals conserved prognostic immune microenvironment features across molecular subtypes in small cell lung cancer.

  2025cites this paper
• Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics

  2025cites this paper
• Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer

  2025cites this paper
• Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer

  2025cites this paper
• ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer

  2025cites this paper
• SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasms

  2025cites this paper
• Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop Accumulation

  2025influential citation
• Prognostic Significance of Immunohistochemical Surrogate Molecular Sub‐Typing of Small Cell Lung Carcinoma

  2025cites this paper
• Filtering cells with high mitochondrial content depletes viable metabolically altered malignant cell populations in cancer single-cell studies

  2025cites this paper
• YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

  2025cites this paper
• Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective

  2025cites this paper
• Identifying reproducible transcription regulator coexpression patterns with single cell transcriptomics

  2025cites this paper
• Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers

  2025cites this paper
• Functional synapses between neurons and small cell lung cancer

  2025cites this paper
• Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes

  2025cites this paper
• Midkine Promotes Tumor Growth and Attenuates the Effect of Cisplatin in Small Cell Lung Cancer

  2025cites this paper
• DeepTFtyper: an interpretable morphology-aware graph neural network for translating histopathology images into molecular subtypes in small cell lung cancer

  2025cites this paper
• Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC

  2025cites this paper
• Challenges of small cell lung cancer heterogeneity and phenotypic plasticity

  2025cites this paper
• Current and future therapies for small cell lung carcinoma

  2025cites this paper
• DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

  2025cites this paper
• Advancing therapeutics in small-cell lung cancer

  2025cites this paper
• Proteogenomic Characterization of High-Grade Lung Neuroendocrine Carcinoma Deciphers Molecular Diversity and Potential Biomarkers of Different Histological Subtypes in Chinese Population

  2025cites this paper
• SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer

  2025cites this paper
• Assessment of targets of antibody drug conjugates in SCLC

  2025cites this paper
• The SWI/SNF chromatin remodeling complex subunit BAF53B as an immunohistochemical marker for neuroendocrine neoplasms

  2025cites this paper
• Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic Vulnerabilities

  2025cites this paper
• Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma

  2025cites this paper
• Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer.

  2025cites this paper
• HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-Driven Small Cell Lung Cancer

  2025cites this paper
• Seizure-Related Homolog Protein 6 (SEZ6): Biology and Therapeutic Target in Neuroendocrine Carcinomas.

  2025cites this paper
• Whole-Slide Imaging and Radiological Features Predict Clinical Outcomes in Patients with Neuroendocrine Tumors of the Lung.

  2025cites this paper
• Deep learning-based histomorphological subtyping and risk stratification of small cell lung cancer from hematoxylin and eosin-stained whole slide images

  2025cites this paper
• DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer

  2025cites this paper
• Deep analysis of the trials and major challenges in the first-line treatment for patients with extensive-stage small cell lung cancer.

  2025cites this paper
• High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader

  2025cites this paper
• Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectives

  2025cites this paper
• Exploring the expression of DLL3 in gastroenteropancreatic neuroendocrine neoplasms and its potential diagnostic value

  2025cites this paper
• Differential expression of the MYC‐Notch axis drives divergent responses to the front‐line therapy in central and peripheral extensive‐stage small‐cell lung cancer

  2025cites this paper
• Jumonji histone demethylases are therapeutic targets in small cell lung cancer

  2024cites this paper
• Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients

  2024cites this paper
• A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples

  2024cites this paper
• Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer

  2024cites this paper
• SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing

  2024influential citation
• Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer

  2024cites this paper
• Current developments in small cell lung cancer

  2024cites this paper
• Integrative analysis of blood transcriptome profiles in small-cell lung cancer patients for identification of novel chemotherapy resistance-related biomarkers

  2024cites this paper
• Spatial Transcriptome‐Wide Profiling of Small Cell Lung Cancer Reveals Intra‐Tumoral Molecular and Subtype Heterogeneity

  2024cites this paper
• DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

  2024cites this paper
• Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma with Prognostic Implications.

  2024cites this paper
• DLL3 as a Potential Diagnostic and Therapeutic Target in Neuroendocrine Neoplasms: A Narrative Review.

  2024cites this paper
• Identifying Reproducible Transcription Regulator Coexpression Patterns with Single Cell Transcriptomics

  2024cites this paper
• Nervous system contributions to small cell lung cancer: Lessons from diverse oncological studies.

  2024cites this paper
• Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes

  2024cites this paper
• Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities

  2024cites this paper
• Crosstalk between cancer-associated fibroblasts and non-neuroendocrine tumor cells in small cell lung cancer involves in glycolysis and antigen-presenting features

  2024cites this paper
• Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer.

  2024cites this paper
• Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer

  2024cites this paper
• Applied models and molecular characteristics of small cell lung cancer

  2024cites this paper
• RepID as a potential biomarker and therapeutic target for lung neuroendocrine tumor

  2024cites this paper
• Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling

  2024influential citation
• Small cell lung cancer and neuroendocrine tumours

  2024cites this paper
• Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions

  2024cites this paper
• Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix

  2024cites this paper
• Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators.

  2024cites this paper
• Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer

  2024cites this paper
• Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

  2024cites this paper
• Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.

  2024cites this paper
• Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer

  2024cites this paper
• Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer

  2024cites this paper
• Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma

  2024cites this paper
• Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities

  2024cites this paper
• Predicting Drug Response of Small Cell Lung Cancer Cell Lines Based on Enrichment Analysis of Complex Gene Signatures.

  2024cites this paper
• Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors

  2024cites this paper
• Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma

  2024cites this paper
• Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma.

  2024cites this paper
• Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.

  2024cites this paper
• ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer

  2024cites this paper
• Filtering cells with high mitochondrial content removes viable metabolically altered malignant cell populations in cancer single-cell studies

  2024cites this paper
• What's in a Name? Replacing Pejorative Terminology in Anatomic Pathology

  2024cites this paper
• Morphological and immunohistochemical prognostic criteria for small cell lung cancers

  2024cites this paper
• The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics

  2024cites this paper
• An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.

  2024cites this paper
• Potential immunologic and prognostic roles of CHRNA6 in SCLC and pan-cancer

  2024cites this paper
• Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment

  2024cites this paper
• Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma

  2023cites this paper
• Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry

  2023cites this paper
• Updates on lung neuroendocrine neoplasm classification

  2023cites this paper
• Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach

  2023cites this paper
• Novel Mouse Cell Lines and In Vivo Models for Human High-Grade Neuroendocrine Lung Carcinoma, Small Cell Lung Carcinoma (SCLC), and Large Cell Neuroendocrine Carcinoma (LCNEC)

  2023cites this paper
• ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer

  2023cites this paper
• Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

  2023cites this paper
• Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature

  2023cites this paper
• YAP1 expression is associated with survival and immunosuppression in small cell lung cancer

  2023cites this paper
• YTHDF2 negatively correlates with tumor immune infiltration in small cell lung cancer

  2023cites this paper